Familial Pancreatic Cancer

[1]  Walter G. Park,et al.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium , 2019, Gut.

[2]  Carol L. Williams,et al.  Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer , 2019, Nature Genetics.

[3]  C. Greenwood,et al.  A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene , 2019, PLoS genetics.

[4]  M. Makary,et al.  Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants , 2019, Modern Pathology.

[5]  Joon-Oh Park,et al.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. , 2019, The New England journal of medicine.

[6]  J. Ross,et al.  Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. , 2019, Gastroenterology.

[7]  L. Wood,et al.  Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. , 2019, Gastroenterology.

[8]  R. Hruban,et al.  Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Berger,et al.  Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms , 2018, Journal of the National Cancer Institute.

[10]  E. Fishman,et al.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. , 2018, Gastroenterology.

[11]  W. Hahn,et al.  Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer , 2018, Genetics in Medicine.

[12]  Raymond M. Moore,et al.  Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer , 2018, JAMA.

[13]  J. Potash,et al.  Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer , 2018, Proceedings of the National Academy of Sciences.

[14]  Richard J. Wenstrup,et al.  PREVALENCE OF GERMLINE MUTATIONS IN CANCER GENES AMONG PANCREATIC CANCER PATIENTS WITH POSITIVE FAMILY HISTORY , 2017, Genetics in Medicine.

[15]  A. Klein,et al.  Inherited pancreatic cancer. , 2017, Chinese clinical oncology.

[16]  I. Machado,et al.  Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier , 2017, World journal of gastrointestinal oncology.

[17]  P. Kantoff,et al.  Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.

[18]  Jin‐Young Jang,et al.  of the pancreas , 2017 .

[19]  Masaya Suenaga,et al.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Cooney,et al.  Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. , 2017, European urology.

[21]  S. Yachida,et al.  Germline mutations in Japanese familial pancreatic cancer patients , 2016, Oncotarget.

[22]  J. Potash,et al.  Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. , 2016, Cancer discovery.

[23]  N. Petrelli,et al.  Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds , 2016, Annals of Surgical Oncology.

[24]  K. Offit,et al.  Identification of germline genetic mutations in patients with pancreatic cancer , 2015, Cancer.

[25]  Raymond M. Moore,et al.  Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[26]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[27]  A. Gylfason,et al.  Loss-of-function variants in ATM confer risk of gastric cancer , 2015, Nature Genetics.

[28]  D. Hedley,et al.  Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  P. Moayyedi,et al.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. , 2015, Gastroenterology.

[30]  G. Petersen,et al.  Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. , 2015, Gastroenterology.

[31]  Michele L Cote,et al.  BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study , 2014, Genetics in Medicine.

[32]  A. Klein.  Identifying people at a high risk of developing pancreatic cancer , 2012, Nature Reviews Cancer.

[33]  A. Klein.  Genetic susceptibility to pancreatic cancer , 2012, Molecular carcinogenesis.

[34]  G. Lahat,et al.  Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition? , 2012, Surgery.

[35]  Yuchen Jiao,et al.  ATM mutations in patients with hereditary pancreatic cancer. , 2012, Cancer discovery.

[36]  Manuel Hidalgo,et al.  Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer , 2010, Molecular Cancer Therapeutics.

[37]  K. Strauch,et al.  PALB2 mutations in European familial pancreatic cancer families , 2010, Clinical genetics.

[38]  S. Gruber,et al.  Risk of pancreatic cancer in families with Lynch syndrome. , 2009, JAMA.

[39]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[40]  S. Puig,et al.  Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.

[41]  A. Goldstein.  Familial melanoma, pancreatic cancer and germline CDKN2A mutations , 2004, Human mutation.

[42]  Alison P. Klein,et al.  Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.

[43]  J. Cameron,et al.  STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. , 2001, The American journal of pathology.

[44]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[45]  N. Gruis,et al.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.

[46]  M. Choti,et al.  Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. , 2000, The American journal of pathology.

[47]  M. Knowles,et al.  Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. , 1998, The New England journal of medicine.

[48]  E. Dimagno,et al.  Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. , 1997, Journal of the National Cancer Institute.

[49]  M. Gorry,et al.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.

[50]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[51]  J. Mouiel,et al.  PANCREATIC CANCER IN MOTHER AND DAUGHTER , 1986, The Lancet.

[52]  J. Fraumeni,et al.  PANCREATIC CANCER IN FATHER AND SON , 1977, The Lancet.

[53]  R. Macdermott,et al.  Adenocarcinoma of the pancreas in four siblings. , 1973, Gastroenterology.